Disclosure 0001817199-26-000032-1

SEC FORM 4

$50,453.92

Nurix Therapeutics, Inc. (NRIX)

Acquisition (code M) of 5,786 shares at $8.72 per share.

Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code M

Traded Oct 2, 2026 · Disclosed Oct 2, 2026

Source: SEC Form 4 · 0001817199-26-000032 · filed 2026-10-02 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Nurix Therapeutics, Inc. (NRIX)." Disclosed 2026-10-02. https://desqlong.com/cards/0001817199-26-000032-1 (retrieved 2026-10-03).